Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 7, 2000, Pages 1980-1982

  Bebear, C M ^a   Renaudin, H ^a   Bryskier, A ^b   Bebear, C ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DIRITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; LEVOFLOXACIN; OFLOXACIN; ROXITHROMYCIN; SPIRAMYCIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN DIFFERENCE; UREAPLASMA UREALYTICUM;

EID: 0033933613     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.7.1980-1982.2000     Document Type: Article

References (17)

1. Bébéar, C., and J. Robertson. 1996. Determination of minimal inhibitory concentration, p. 189-199. In J. G. Tully and S. Razin (ed.), Molecular and diagnostic procedures in mycoplasmology, vol. II. Academic Press, Inc., San Diego, Calif.
2. Bébéar, C. M., H. Renaudin, M. D. Aydin, J. F. Chantot, and C. Bébéar. 1997. In-vitro activity of ketolides against mycoplasmas. J. Antimicrob. Chemother. 39:669-670.
3. Bébéar, C. M., H. Renaudin, A. Boudjadja, and C. Bébéar. 1998. In vitro activity of BAY 12-8039, a new fluoroquinolone, against mycoplasmas. Antimicrob. Agents Chemother. 42:703-704.
4. Bébéar, C. M., H. Renaudin, T. Schaeverbeke, F. Leblanc, and C. Bébéar. 1999. In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. J. Antimicrob. Chemother. 43:711-714.
5. Bébéar, C. M., J. Renaudin, A. Charron, H. Renaudin, B. de Barbeyrac, T. Schaeverbeke, and C. Bébéar. 1999. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob. Agents Chemother. 43:954-956.
6. Bryskier, A., C. Agouridas, and J. F. Chantot. 1997. Ketolide: new semisynthetic 14-membered ring macrolide, p. 39-50. In S. H. Zinner, L. S. Young, J. P. Acar, and H. C. Neu (ed.). Expanding indications for the new macrolides, azalides and streptogramins. Marcel Dekker, Inc., New York, N.Y.
7. Kenny, G. E., and F. D. Cartwright. 1996. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219). Antimicrob. Agents Chemother. 40: 1048-1049.
8. Malathum, K., T. M. Coque, K. V. Singh, and B. M. Murray. 1999. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob. Agents Chemother. 43:930-936.
9. Piddock, L. J. 1994. New quinolones and gram-positive bacteria. Antimicrob. Agents Chemother. 38:163-169.
10. Reinert, R. R., R. Lütticken, M. Lemperle, and A. Bryskier. 1999. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae. J. Antimicrob. Chemother. 43(Suppl. C):5-8.
11. Ridgway, G. L., H. Salman, M. J. Robbins, C. Dencer, and D. Felmingham. 1997. The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. J. Antimicrob. Chemother. 40(Suppl. A):31-34.
12. Roberts, M. C., and G. E. Kenny. 1986. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob. Agents Chemother. 29:350-352.
13. Roberts, M. C., L. A. Koutsky, K. K. Holmes, D. J. LeBlanc, and G. E. Kenny. 1985. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob. Agents Chemother. 28:141-143.
14. Soussy, C.-J., M. Cluzel, M.-C. Ploy, M-D. Kitzis, D. Morel, A. Bryskier, and P. Courvalin. 1999. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study. J. Antimicrob. Chemother. 43(Suppl. C):43-50.
15. Taylor-Robinson, D., and C. Bébéar. 1997. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J. Antimicrob. Chemother. 40:622-630.
16. Ullmann, U., S. Schubert, and R. Krausse. 1999. Comparative in vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J. Antimicrob. Chemother. 43(Suppl. C):33-36.
17. Waites, K. B., K. C. Canupp, and G. E. Kenny. 1999. In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob. Agents Chemother. 43:2571-2573.